Recruiting Heart Attack Studies in Carmel
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
This is a study to evaluate the efficacy and safety of AZD0780 in adults with HeFH and elevated LDL-C, either with clinical ASCVD and LDL-C levels of 55 mg/dL or higher or without clinical ASCVD and L...
Post-Operative Thoracolumosacral Orthosis for PJK
Proximal junctional kyphosis (PJK) is a common post-operative radiographic finding after surgery for adult spinal deformity (ASD) patients. Although the clinical relevance of isolated PJK is unclear, ...
About Heart Attack Clinical Trials in Carmel
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Carmel, IN. These studies are seeking a combined 489 participants. Research is being sponsored by AstraZeneca, Hospital for Special Surgery, New York. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Carmel — FAQ
Are there heart attack clinical trials in Carmel?
Yes, there are 2 heart attack clinical trials currently recruiting in Carmel, IN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Carmel?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Carmel research site will contact you about next steps.
Are clinical trials in Carmel free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Carmel studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Carmel are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov